Development of Apoptotic Cell Mimetic Anti-inflammatory Polymers
The field of biomaterials has seen a strong rejuvenation due to the new potential to modulate immune system in our body. This special class of materials is called “immunomodulatory biomaterials”. Generally, three fundamental strategies are followed in the design of immunomodulatory biomaterials：（1）i...
Saved in:
| Published in | Drug Delivery System Vol. 37; no. 2; pp. 149 - 158 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Japanese |
| Published |
Kawasaki
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
25.03.2022
Japan Science and Technology Agency |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0913-5006 1881-2732 1881-2732 |
| DOI | 10.2745/dds.37.149 |
Cover
| Abstract | The field of biomaterials has seen a strong rejuvenation due to the new potential to modulate immune system in our body. This special class of materials is called “immunomodulatory biomaterials”. Generally, three fundamental strategies are followed in the design of immunomodulatory biomaterials：（1）immuno-inert biomaterials, （2）immuno-activating biomaterials, and （3）immuno-tolerant biomaterials. While many applications of immuno-inert biomaterials such as biocompatible medical implants have been already proposed in the past decades, the ability to engineer biological activity into synthetic materials greatly increases the number of their potential uses and improves their performance in more traditional applications. The major focus of researchers is now set on developing immuno-tolerant biomaterials for anti-inflammatory therapies. In this review, we therefore introduce recent developments of immuno-tolerant biomaterials. Especially we introduce an apoptotic cell membrane inspired polymer and its post-inflammatory effects on immune cells in this article. |
|---|---|
| AbstractList | The field of biomaterials has seen a strong rejuvenation due to the new potential to modulate immune system in our body. This special class of materials is called “immunomodulatory biomaterials”. Generally, three fundamental strategies are followed in the design of immunomodulatory biomaterials：（1）immuno-inert biomaterials, （2）immuno-activating biomaterials, and （3）immuno-tolerant biomaterials. While many applications of immuno-inert biomaterials such as biocompatible medical implants have been already proposed in the past decades, the ability to engineer biological activity into synthetic materials greatly increases the number of their potential uses and improves their performance in more traditional applications. The major focus of researchers is now set on developing immuno-tolerant biomaterials for anti-inflammatory therapies. In this review, we therefore introduce recent developments of immuno-tolerant biomaterials. Especially we introduce an apoptotic cell membrane inspired polymer and its post-inflammatory effects on immune cells in this article. |
| Author | Ebara, Mitsuhiro Tasaki, Akari |
| Author_xml | – sequence: 1 fullname: Tasaki, Akari organization: Graduate School of Pure and Applied Sciences, University of Tsukuba – sequence: 1 fullname: Ebara, Mitsuhiro organization: Graduate School of Pure and Applied Sciences, University of Tsukuba |
| BookMark | eNo9j11LwzAUQINMcE5f_AUFH6UzX0vSB8ExP2GiD_ocsuZWO9KkJp3Sf2_H5p7CzT0c7jlFIx88IHRB8JRKPru2Nk2ZnBJeHKExUYrkVDI6QmNcEJbPMBYn6DSlNcZ8WJIxur2DH3ChbcB3WaiyeRvaLnR1mS3AueylbmA7zH1X57WvnGka04XYZ2_B9Q3EdIaOK-MSnO_fCfp4uH9fPOXL18fnxXyZl1TwIrd8ZSQXhChs5IyuqOFKSmGZpRIAqFIURMUtWFNZXMpSMbCFErSyTJZYsQm62nk3vjX9r3FOt7FuTOw1wXobr4d4zaQe4gf6cke3MXxvIHV6HTbRDwdqKhQjkgmCB-pmR61TZz7hIDRxaHbwL6R76-G__DJRg2d_u6pxew |
| CitedBy_id | crossref_primary_10_2745_dds_38_379 |
| ContentType | Journal Article |
| Copyright | 2022 The Japan Society of Drug Delivery System Copyright Japan Science and Technology Agency 2022 |
| Copyright_xml | – notice: 2022 The Japan Society of Drug Delivery System – notice: Copyright Japan Science and Technology Agency 2022 |
| DBID | 7QO 8FD FR3 P64 ADTOC UNPAY |
| DOI | 10.2745/dds.37.149 |
| DatabaseName | Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
| DatabaseTitleList | Engineering Research Database |
| Database_xml | – sequence: 1 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1881-2732 |
| EndPage | 158 |
| ExternalDocumentID | 10.2745/dds.37.149 article_dds_37_2_37_149_article_char_en |
| GroupedDBID | .55 2WC 53G 5GY ACIWK ACPRK AFRAH ALMA_UNASSIGNED_HOLDINGS AUIBY CS3 JSF JSH OK1 RJT RZJ X7M 7QO 8FD FR3 P64 3O- ADTOC AL- TKC UNPAY |
| ID | FETCH-LOGICAL-c2649-d4ba7461180a752b2a48776d3d27eee2882e6f4dedafd0c7c83ed9862fd37c083 |
| IEDL.DBID | UNPAY |
| ISSN | 0913-5006 1881-2732 |
| IngestDate | Tue Aug 19 22:23:11 EDT 2025 Sat Sep 20 14:20:59 EDT 2025 Wed Sep 03 06:31:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2649-d4ba7461180a752b2a48776d3d27eee2882e6f4dedafd0c7c83ed9862fd37c083 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/dds/37/2/37_149/_pdf |
| PQID | 2683173610 |
| PQPubID | 2048468 |
| PageCount | 10 |
| ParticipantIDs | unpaywall_primary_10_2745_dds_37_149 proquest_journals_2683173610 jstage_primary_article_dds_37_2_37_149_article_char_en |
| PublicationCentury | 2000 |
| PublicationDate | 2022/03/25 |
| PublicationDateYYYYMMDD | 2022-03-25 |
| PublicationDate_xml | – month: 03 year: 2022 text: 2022/03/25 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | Kawasaki |
| PublicationPlace_xml | – name: Kawasaki |
| PublicationTitle | Drug Delivery System |
| PublicationTitleAlternate | DDS |
| PublicationYear | 2022 |
| Publisher | THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM Japan Science and Technology Agency |
| Publisher_xml | – name: THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM – name: Japan Science and Technology Agency |
| References | 23）Fadok V.A., et al., Nature, 405, 85-90 （2000 43）Malachowski T., et al., Engineered Regeneration, 1, 35-50 （2020 50）Champion J.A., et al., PNAS, 103, 4930-4934 （2006 35）Wu Z., et al., J. Immunol., 6, 3191-3201 （2010 53）Dasgupta S., et al., Nano Lett., 14, 687-693 （2014 57）Yang Q., et al., Mol. Pharm., 11, 1250-1258 （2014 12）Liu J.M.H., et al., Biomaterials, 80, 11-19 （2016 48）Getts D.R., et al., Sci. Transl. Med., 6, 219ra7 （2014 49）Kelley W.J., et al., ACS Biomater. Sci. Eng., 5, 6530-6540 （2019 6）Garvey L.H., et al., Br. J. Anaesth., 126, e106-e108 （2021 58）Walkey C.D., et al., J. Am. Chem. Soc., 134, 2139-2147 （2012 27）Kim S., et al., Mol. Cell. Biol., 32, 2698-2708 （2012 16）Shashni B., et al., Biomaterials, 275, 120877 （2021 29）Freeman G.J., et al., Immunol. Rev., 235, 172-189 （2010 36）Quan H., et al., J. Biomed. Mater. Res., 105, 1479-1486 （2017 2）Moro T., et al., Osteoarthritis Cartilage, 18, 1174-1182 （2010 18）Alyssa M. Flores., et al., Nat. Nanotechnol., 15, 154-161 （2020 61）Moghimi S.M., et al., J. Control. Release, 146, 175-181 （2010 60）Kozma G.T., et al., ACS Nano, 13, 9315-9324 （2019 32）Yeom M., et al., Nut. Res., 33, 242-250 （2013 59）Perry J.L., et al., Nano Lett., 12, 5304-5310 （2012 41）Li L., et al., J. Neuroinflammation, 11, 72 （2014 14）Freitag T.L., et al., Gastroenterology, 158, 1667-1681 （2020 33）Nian M., et al., Circ. Res., 12, 1543-1553 （2004 37）Nakagawa Y., et al., ACS Macro Let., 6, 1020-1024 （2017 52）Yoo J. W., et al., Curr. Pharm. Des., 16, 2298-2307 （2010 42）Nicolete R., et al., Int. Immunopharmacol., 11, 1557-1563 （2011 39）Nakagawa Y., et al., ACS Biomater. Sci. Eng., 5705-5713 （2019 11）Kwon Y.J., et al., Mol. Pharm., 2, 83-91 （2005 15）Jacob N., et al., Sci. Rep., 10, 19120 （2020 24）Fadok V.A., et al., Cell Death Differ., 8, 582-587 （2001 8）Jiang W., et al., Adv. Drug Deliv. Rev., 57, 391-410 （2005 47）Pradal J., et al., Int. J. Pharm., 498, 119-129 （2016 21）Segawa K., et al., Science, 344, 1164-1168 （2014 13）Kuo R., et al., Mol. Ther., 25, 1676-1685 （2017 26）Flannagan R.S., et al., Annu. Rev. Pathol., 7, 61-98 （2012 5）Sellaturay P., J. Allergy Clin. Immunol. Pract., 9, 670-675 （2021 10）Kwon Y.J., et al., Proc. Natl. Acad. Sci. USA, 102, 18264-18268 （2005 17）Holman N.S., et al., Toxicol. Sci., 170, 499-508 （2019 40）Liu Y.C., et al., Int. J. Biol. Sci., 10, 520-529 （2014 22）Birge R.B., et al., Cell Death Differ., 23, 962-978 （2016 56）He C., et al., Biomaterials, 31, 3657-3666 （2010 55）Zauner W., et al., J. Control. Release, 71, 39-51 （2001 34）Hashioka S., et al., Free Radic. Biol. Med., 7, 945-954 （2007 20）Voll R.E., et al., Nature, 390, 350-351 （1997 7）Nilsson J.S., et al., Acta Otolaryngol., 134, 1034-1041 （2014 4）Wenande E., et al., Clin. Exp. Allergy, 46, 907-922 （2016 1）Ishihara K., J. Biomater. Appl., 13, 111-127 （1998 45）Pratten M.K., et al., Biochim. Biophys. Acta, 881, 307-313 （1986 9）Benoit M.A., Int. J. Pharm., 184, 73-84 （1999 51）Champion J.A., et al., Pharm. Res., 26, 244-249 （2009 19）Smith B.R., et al., Nat. Nanotechnol., 9, 481-487 （2014 30）Smith C.M., et al., Biochem. J., 478, 3331-3349 （2021 38）Nakagawa Y., et al., Polymer, 134, 85-93 （2018 54）Safari H., et al., Sci. Adv., 6, eaba1474 （2020 46）Kuhn D.A., et al., Beilstein J. Nanotechnol., 5, 1625-1636 （2014 31）Kapty J., et al., J. Biomol. Screen., 17, 1293-1301 （2012 44）Chen K.H., et al., Nanoscale, 7, 15863-15872 （2015 25）Fadok V.A., et al., J. Clin. Invest., 4, 890-898 （1998 3）Uchida K., et al., Biointerphases, 2, 126-30 （2007 28）Yanagihashi Y., et al., PNAS, 114, 8800-8805 （2017 |
| References_xml | – reference: 54）Safari H., et al., Sci. Adv., 6, eaba1474 （2020） – reference: 28）Yanagihashi Y., et al., PNAS, 114, 8800-8805 （2017） – reference: 12）Liu J.M.H., et al., Biomaterials, 80, 11-19 （2016） – reference: 33）Nian M., et al., Circ. Res., 12, 1543-1553 （2004） – reference: 36）Quan H., et al., J. Biomed. Mater. Res., 105, 1479-1486 （2017） – reference: 13）Kuo R., et al., Mol. Ther., 25, 1676-1685 （2017） – reference: 31）Kapty J., et al., J. Biomol. Screen., 17, 1293-1301 （2012） – reference: 60）Kozma G.T., et al., ACS Nano, 13, 9315-9324 （2019） – reference: 42）Nicolete R., et al., Int. Immunopharmacol., 11, 1557-1563 （2011） – reference: 10）Kwon Y.J., et al., Proc. Natl. Acad. Sci. USA, 102, 18264-18268 （2005） – reference: 11）Kwon Y.J., et al., Mol. Pharm., 2, 83-91 （2005） – reference: 58）Walkey C.D., et al., J. Am. Chem. Soc., 134, 2139-2147 （2012） – reference: 46）Kuhn D.A., et al., Beilstein J. Nanotechnol., 5, 1625-1636 （2014） – reference: 48）Getts D.R., et al., Sci. Transl. Med., 6, 219ra7 （2014） – reference: 52）Yoo J. W., et al., Curr. Pharm. Des., 16, 2298-2307 （2010） – reference: 15）Jacob N., et al., Sci. Rep., 10, 19120 （2020） – reference: 5）Sellaturay P., J. Allergy Clin. Immunol. Pract., 9, 670-675 （2021） – reference: 2）Moro T., et al., Osteoarthritis Cartilage, 18, 1174-1182 （2010） – reference: 24）Fadok V.A., et al., Cell Death Differ., 8, 582-587 （2001） – reference: 39）Nakagawa Y., et al., ACS Biomater. Sci. Eng., 5705-5713 （2019） – reference: 29）Freeman G.J., et al., Immunol. Rev., 235, 172-189 （2010） – reference: 38）Nakagawa Y., et al., Polymer, 134, 85-93 （2018） – reference: 50）Champion J.A., et al., PNAS, 103, 4930-4934 （2006） – reference: 21）Segawa K., et al., Science, 344, 1164-1168 （2014） – reference: 53）Dasgupta S., et al., Nano Lett., 14, 687-693 （2014） – reference: 47）Pradal J., et al., Int. J. Pharm., 498, 119-129 （2016） – reference: 16）Shashni B., et al., Biomaterials, 275, 120877 （2021） – reference: 8）Jiang W., et al., Adv. Drug Deliv. Rev., 57, 391-410 （2005） – reference: 59）Perry J.L., et al., Nano Lett., 12, 5304-5310 （2012） – reference: 22）Birge R.B., et al., Cell Death Differ., 23, 962-978 （2016） – reference: 23）Fadok V.A., et al., Nature, 405, 85-90 （2000） – reference: 51）Champion J.A., et al., Pharm. Res., 26, 244-249 （2009） – reference: 41）Li L., et al., J. Neuroinflammation, 11, 72 （2014） – reference: 56）He C., et al., Biomaterials, 31, 3657-3666 （2010） – reference: 25）Fadok V.A., et al., J. Clin. Invest., 4, 890-898 （1998） – reference: 55）Zauner W., et al., J. Control. Release, 71, 39-51 （2001） – reference: 45）Pratten M.K., et al., Biochim. Biophys. Acta, 881, 307-313 （1986） – reference: 43）Malachowski T., et al., Engineered Regeneration, 1, 35-50 （2020） – reference: 3）Uchida K., et al., Biointerphases, 2, 126-30 （2007） – reference: 40）Liu Y.C., et al., Int. J. Biol. Sci., 10, 520-529 （2014） – reference: 34）Hashioka S., et al., Free Radic. Biol. Med., 7, 945-954 （2007） – reference: 44）Chen K.H., et al., Nanoscale, 7, 15863-15872 （2015） – reference: 27）Kim S., et al., Mol. Cell. Biol., 32, 2698-2708 （2012） – reference: 20）Voll R.E., et al., Nature, 390, 350-351 （1997） – reference: 17）Holman N.S., et al., Toxicol. Sci., 170, 499-508 （2019） – reference: 14）Freitag T.L., et al., Gastroenterology, 158, 1667-1681 （2020） – reference: 49）Kelley W.J., et al., ACS Biomater. Sci. Eng., 5, 6530-6540 （2019） – reference: 1）Ishihara K., J. Biomater. Appl., 13, 111-127 （1998） – reference: 19）Smith B.R., et al., Nat. Nanotechnol., 9, 481-487 （2014） – reference: 4）Wenande E., et al., Clin. Exp. Allergy, 46, 907-922 （2016） – reference: 32）Yeom M., et al., Nut. Res., 33, 242-250 （2013） – reference: 18）Alyssa M. Flores., et al., Nat. Nanotechnol., 15, 154-161 （2020） – reference: 35）Wu Z., et al., J. Immunol., 6, 3191-3201 （2010） – reference: 37）Nakagawa Y., et al., ACS Macro Let., 6, 1020-1024 （2017） – reference: 6）Garvey L.H., et al., Br. J. Anaesth., 126, e106-e108 （2021） – reference: 30）Smith C.M., et al., Biochem. J., 478, 3331-3349 （2021） – reference: 61）Moghimi S.M., et al., J. Control. Release, 146, 175-181 （2010） – reference: 9）Benoit M.A., Int. J. Pharm., 184, 73-84 （1999） – reference: 7）Nilsson J.S., et al., Acta Otolaryngol., 134, 1034-1041 （2014） – reference: 26）Flannagan R.S., et al., Annu. Rev. Pathol., 7, 61-98 （2012） – reference: 57）Yang Q., et al., Mol. Pharm., 11, 1250-1258 （2014） |
| SSID | ssj0048811 ssib058492641 ssib007483962 ssib001535732 ssib002484529 |
| Score | 2.1843812 |
| Snippet | The field of biomaterials has seen a strong rejuvenation due to the new potential to modulate immune system in our body. This special class of materials is... |
| SourceID | unpaywall proquest jstage |
| SourceType | Open Access Repository Aggregation Database Publisher |
| StartPage | 149 |
| SubjectTerms | anti-inflammatory Apoptosis apoptotic cells Biocompatibility Biological activity Biomaterials Biomedical materials Cell membranes Immune system Immunomodulation Inflammation MPS Polymers Surgical implants |
| Title | Development of Apoptotic Cell Mimetic Anti-inflammatory Polymers |
| URI | https://www.jstage.jst.go.jp/article/dds/37/2/37_149/_article/-char/en https://www.proquest.com/docview/2683173610 https://www.jstage.jst.go.jp/article/dds/37/2/37_149/_pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 37 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Drug Delivery System, 2022/03/25, Vol.37(2), pp.149-158 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 1881-2732 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib007483962 issn: 0913-5006 databaseCode: KQ8 dateStart: 19860101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEC50POxe1sfusuOLPoinyasf6eTmIA6yizKCA7N7CUm6I2pMgpNBxl9v9STz0NMigQRCU-lUV1e-Sld9DXDiyszXYepaSZJ5ZplRoB8MYgvdZRqKDA9haoevrv3LEf89FuO1rb5MWuUD4qI7bS72XWk_VE6rREepicOkQ_GEkDV0okplm7DlC4ThHdgaXQ_7f-fceh6zhDvfV9MLAs-Un9CGmhRjMGHE2EyijzD8mc3D3uHLL9OiimcvcZ6vfWoG2_Bv0ckmw-TRntaJnb5-4G_81FvswLcWgJJ-02wXNnSxB6fDhsF61iO3q4KsSY-ckuGK23r2Hc7WkoxImZF-VVZ1iW3Juc5zcnX_ZIoiSb-o7y20XTS3p_kyPhmW-cz8Iv8Bo8HF7fml1W7CYKWIlUJL8SSW3DdMcbEUNKExhjjSV0xRqbWmiNC1n3GlVZwpN5VpwLQKMU7KFJMpAryf0CnKQv8Cog33H3oQLjXjPNWBxyWiyURRnoiYiy74jdKiqmHaiFqVRaiyCLVFo0Zly_umMg2ndxcOF6MXtVNwElE_QGzEEB524WQ5okvRGPwYY1iIRqn7_9fsAL5SUwLhMouKQ-jUz1N9hMCkTo5h889NcNwa4hsVvuSG |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50PejFt7i-yEE82VceTXtzEUUEZQ8uqJfSNqmotS1uF1l_vZNtd109iRRaKGGaTibTb5qZLwDHrsx8HaaulSSZZ5YZBfrBILbQXaahyPAQpnb45ta_GvDre3E_t9WXSat8QVz0pM3Ffirtl8pplegoNXSYdCieELKGTlSpbBGWfIEwvANLg9t-72HCrecxS7iTfTW9IPBM-QltqEkxBhNGjM0k-gjDn9k87Ae-XB4VVTz-iPN87lNzuQaP0042GSav9qhO7PTzF3_jv95iHVZbAEp6TbMNWNDFJpz0Gwbr8Sm5-y7IGp6SE9L_5rYeb8HZXJIRKTPSq8qqLrEtOdd5Tm6e30xRJOkV9bOFtovm9jZZxif9Mh-bX-TbMLi8uDu_stpNGKwUsVJoKZ7EkvuGKS6WgiY0xhBH-oopKrXWFBG69jOutIoz5aYyDZhWIcZJmWIyRYC3A52iLPQuEG24_9CDcKkZ56kOPC4RTSaK8kTEXHTBb5QWVQ3TRtSqLEKVRagtGjUqm903lWk4vbtwMB29qJ2Cw4j6AWIjhvCwC8ezEZ2JxuDHGMNUNErd-1uzfVihpgTCZRYVB9Cp30f6EIFJnRy1JvgFv_vjkQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Apoptotic+Cell+Mimetic+Anti-inflammatory+Polymers&rft.jtitle=Drug+delivery+system&rft.au=Tasaki%2C+Akari&rft.au=Ebara%2C+Mitsuhiro&rft.au=%E6%9C%B1%E9%87%8C%2C+%E7%94%B0%E5%B4%8E&rft.au=%E5%85%85%E5%AE%8F%2C+%E8%8D%8F%E5%8E%9F&rft.date=2022-03-25&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0913-5006&rft.eissn=1881-2732&rft.volume=37&rft.issue=2&rft.spage=149&rft_id=info:doi/10.2745%2Fdds.37.149&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-5006&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-5006&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-5006&client=summon |